[go: up one dir, main page]

GB0222409D0 - Use of antitumoral compounds in cancer therapy - Google Patents

Use of antitumoral compounds in cancer therapy

Info

Publication number
GB0222409D0
GB0222409D0 GB0222409A GB0222409A GB0222409D0 GB 0222409 D0 GB0222409 D0 GB 0222409D0 GB 0222409 A GB0222409 A GB 0222409A GB 0222409 A GB0222409 A GB 0222409A GB 0222409 D0 GB0222409 D0 GB 0222409D0
Authority
GB
United Kingdom
Prior art keywords
cancer therapy
antitumoral compounds
antitumoral
compounds
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0222409A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Priority to GB0222409A priority Critical patent/GB0222409D0/en
Priority to MXPA04003672A priority patent/MXPA04003672A/en
Priority to PCT/GB2002/004735 priority patent/WO2003033012A1/en
Priority to EP02801430A priority patent/EP1435990A1/en
Priority to CA002462639A priority patent/CA2462639A1/en
Priority to AU2002334203A priority patent/AU2002334203C1/en
Publication of GB0222409D0 publication Critical patent/GB0222409D0/en
Ceased legal-status Critical Current

Links

GB0222409A 2001-10-19 2002-09-26 Use of antitumoral compounds in cancer therapy Ceased GB0222409D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB0222409A GB0222409D0 (en) 2002-09-26 2002-09-26 Use of antitumoral compounds in cancer therapy
MXPA04003672A MXPA04003672A (en) 2001-10-19 2002-10-18 Kahalalide f formulation.
PCT/GB2002/004735 WO2003033012A1 (en) 2001-10-19 2002-10-18 Kahalalide compounds for use in cancer therapy
EP02801430A EP1435990A1 (en) 2001-10-19 2002-10-18 Kahalalide compounds for use in cancer therapy
CA002462639A CA2462639A1 (en) 2001-10-19 2002-10-18 Kahalalide compounds for use in cancer therapy
AU2002334203A AU2002334203C1 (en) 2001-10-19 2002-10-18 Kahalalide compounds for use in cancer therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0222409A GB0222409D0 (en) 2002-09-26 2002-09-26 Use of antitumoral compounds in cancer therapy

Publications (1)

Publication Number Publication Date
GB0222409D0 true GB0222409D0 (en) 2002-11-06

Family

ID=9944840

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0222409A Ceased GB0222409D0 (en) 2001-10-19 2002-09-26 Use of antitumoral compounds in cancer therapy

Country Status (1)

Country Link
GB (1) GB0222409D0 (en)

Similar Documents

Publication Publication Date Title
IL164599A0 (en) Combination therapy for the treatment of cancer
EP1482970A4 (en) Cancer therapy
GB0324761D0 (en) Use of compounds in therapy
EP1435988A4 (en) Improved use of antitumoral compound in cancer therapy
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
IL172316A0 (en) Novel compounds and their use in therapy
IL173576A0 (en) Use of polypeptides of the cupredoxin family in cancer therapy
AU2003212634A8 (en) Compounds useful in the treatment of cancer
GB0223367D0 (en) Therapeutic treatment
GB0223854D0 (en) Therapeutic treatment
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
GB0219660D0 (en) Therapeutic use
GB0207410D0 (en) Compounds and their therapeutic use
LT1496918T (en) Use of sodium meta-arsenite for the treatment of tumours
GB0210741D0 (en) Methods of therapy
GB0210464D0 (en) Therapeutic treatment
GB0226595D0 (en) Cancer therapy determination
AU2003231803A8 (en) Treatment of cancer with mefloquire
EP1583543A4 (en) Methods and therapeutic compositions in the treatment of advanced cancer
GB0329416D0 (en) Treatment of cancer
GB0222409D0 (en) Use of antitumoral compounds in cancer therapy
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
IL175774A0 (en) Use of siramesine in the treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)